Loading clinical trials...
Loading clinical trials...
Eat Well Produce Prescription for Duke Health Patients With Congestive Heart Failure
The purpose of this parallel pragmatic randomized controlled trial (RCT) is to evaluate the impact of Eat Well (an evidence-based 'Food is Medicine' produce prescription program) with varying levels of behavioral support on health outcomes and care utilization patterns of Duke Health patients diagnosed with congestive heart failure (CHF). Objectives of this three arm trial include testing the effectiveness of Eat Well alone with minimal behavioral support and Eat Well with intensified behavioral support based on an evidence based approach to improve CHF patients' health outcomes, estimating health care cost savings between the intervention and control arms, and identifying barriers, facilitators, and potential strategies to enhance Eat Well effectiveness and implementation.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Duke Health
Durham, North Carolina, United States
Start Date
October 22, 2025
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2027
Last Updated
November 12, 2025
900
ESTIMATED participants
Personal health planning and nutritional coaching
BEHAVIORAL
Prescription Produce
OTHER
Lead Sponsor
Duke University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions